Journal
LEUKEMIA RESEARCH
Volume 34, Issue 6, Pages 698-699Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.leukres.2009.12.009
Keywords
Chronic myeloid leukemia; Pharmacokinetics; Pharmacodynamics; Therapeutic drug monitoring; Prognostic factors; Imatinib; Nilotinib